Trademark Alertz ®
Search
Trademark
Owner
Trademark: ANOCCA 2060215
Word
ANOCCA
Device Descrption:
DISC-HEAD IN OVAL,IRREGULAR
ID
2060215
Trademark Type
Figurative
Status
Protected: Registered/protected
Application Date
16 July 2019
Registration Date
16 July 2019
Renewal Date
16 July 2029
Owner(s)
Anocca AB
Service
Goods and Services:
Class 1
:
Biochemicals, namely for in vitro genetic engineering use
;
biochemicals, namely for ex vivo genetic engineering use
;
biochemicals, namely precursors for in vitro genetic engineering use
;
biochemicals, namely precursors for ex vivo genetic engineering use
;
biological preparations
;
biological preparations, namely, for in vitro genetic engineering use
;
biological preparations, for ex vivo genetic engineering use
;
biological preparations, precursors for in vitro genetic engineering use
;
biological preparations, precursors for ex vivo genetic engineering use
;
biological preparations for use in manufacture
;
biological preparations, other than for medical or veterinary purposes
;
biological tissue cultures, other than for medical or veterinary purposes
;
biological preparations [other than for medical use]
;
biological preparations for use in industry and science
;
chemical reagents for molecular biology, other than for medical or veterinary use
;
chemical reagents for use in biotechnology, other than for medical or veterinary use
;
chemical reagents, namely, for in vitro genetic engineering use
;
chemical reagents, for ex vivo genetic engineering use
;
chemical reagents, precursors for in vitro genetic engineering use
;
chemical reagents, precursors for ex vivo genetic engineering use
;
diagnostic preparations, other than for medical or veterinary purposes
;
diagnostic preparations, namely, for in vitro genetic engineering use
;
diagnostic preparations, for ex vivo genetic engineering use
;
diagnostic preparations, precursors for in vitro genetic engineering use
;
diagnostic preparations, precursors for ex vivo genetic engineering use
;
immunoassay reagents, other than for medical use
;
immunoassay reagents, namely, for in vitro genetic engineering use
;
immunoassay reagents, for ex vivo genetic engineering use
;
immunoassay reagents, precursors for in vitro genetic engineering use
;
immunoassay reagents, precursors for ex vivo genetic engineering use
;
immunoassays based on polypeptides for determining immunological profile, other than for medical use
;
reagents for use in immunoserology
;
reagents, namely, for in vitro genetic engineering use
;
reagents, namely, for ex vivo genetic engineering use
;
reagents, namely, precursors for in vitro genetic engineering use
;
reagents, namely, precursors for ex vivo genetic engineering use.
Class 5
:
Biological preparations for veterinary and medical purposes
;
biological preparations for ex vivo gene engineering
;
biological preparations for cellular therapeutics
;
biological preparations for cellular therapy
;
biological preparations for cell therapy
;
biological preparations for treatment of deceases using cells
;
biological preparations for medical purposes
;
biological preparations for treatment of cancer
;
biological tissue cultures for medical purposes
;
cellular function activating agents for medical purposes
;
diagnostic biomarker reagents for medical purposes
;
diagnostic preparation and materials for veterinary and medical purposes
;
diagnostic preparation for medical use
;
diagnostic preparations
;
diagnostic preparations for medical purposes
;
immunoassay reagents for medical use
;
immunomodulators
;
immunostimulants
;
in vitro diagnostic preparation for medical use
;
mixed biological preparations for medical purposes
;
personalized antigens
;
personalized tumour antigens
;
personalized tumour vaccines
;
personalized vaccines
;
pharmaceutical compositions
;
pharmaceutical compositions and substances with anti-inflammatory properties
;
pharmaceutical compositions for the prevention of autoimmune conditions
;
pharmaceutical compositions for the prevention of autoimmune diseases
;
pharmaceutical compositions for the prevention of autoimmune disorders
;
pharmaceutical compositions for the prevention of inflammatory conditions
;
pharmaceutical compositions for the prevention of inflammatory disorders
;
pharmaceutical compositions for the prevention of inflammatory diseases
;
pharmaceutical compositions for the prevention of oncological conditions
;
pharmaceutical compositions for the prevention of oncological disorders
;
pharmaceutical compositions for the prevention of oncological diseases
;
pharmaceutical compositions for the prevention of tumours
;
pharmaceutical compositions for the treatment of autoimmune conditions
;
pharmaceutical compositions for the treatment of autoimmune diseases
;
pharmaceutical compositions for the treatment of autoimmune disorders
;
pharmaceutical compositions for the treatment of inflammatory conditions
;
pharmaceutical compositions for the treatment of inflammatory disorders
;
pharmaceutical compositions for the treatment of inflammatory diseases
;
pharmaceutical compositions for the treatment of oncological conditions
;
pharmaceutical compositions for the treatment of oncological diseases
;
pharmaceutical compositions for the treatment of oncological disorders
;
pharmaceutical compositions for the treatment of tumours
;
pharmaceutical preparations
;
pharmaceutical preparations and substances
;
pharmaceutical preparations and substances for the prevention of cancer
;
pharmaceutical preparations and substances for the treatment of cancer
;
pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases
;
pharmaceutical preparations and substances for use in oncology
;
pharmaceutical preparations and substances with anti-inflammatory properties
;
pharmaceutical preparations for activating cellular function
;
pharmaceutical preparations for human use
;
pharmaceutical preparations for immunity adjustment
;
pharmaceutical preparations for medical purposes
;
pharmaceutical preparations for prevention of tumours
;
pharmaceutical preparations for regulating the immune system
;
pharmaceutical preparations for suppressing tumors
;
pharmaceutical preparations for the prevention of autoimmune conditions
;
pharmaceutical preparations for the prevention of autoimmune diseases
;
pharmaceutical preparations for the prevention of autoimmune disorders
;
pharmaceutical preparations for the prevention of diseases of the immune system
;
pharmaceutical preparations for the prevention of disorders of the immune system
;
pharmaceutical preparations for the prevention of inflammatory conditions
;
pharmaceutical preparations for the prevention of inflammatory disorders
;
pharmaceutical preparations for the prevention of inflammatory diseases
;
pharmaceutical preparations for the prevention of oncological conditions
;
pharmaceutical preparations for the prevention of oncological disorders
;
pharmaceutical preparations for the prevention of oncological diseases
;
pharmaceutical preparations for the treatment of autoimmune conditions
;
pharmaceutical preparations for the treatment of autoimmune diseases
;
pharmaceutical preparations for the treatment of autoimmune disorders
;
pharmaceutical preparations for the treatment of digestive diseases
;
pharmaceutical preparations for the treatment of gout
;
pharmaceutical preparations for the treatment of immune system related diseases and disorders
;
pharmaceutical preparations for the treatment of inflammatory conditions
;
pharmaceutical preparations for the treatment of inflammatory disorders
;
pharmaceutical preparations for the treatment of inflammatory diseases
;
pharmaceutical preparations for the treatment of oncological conditions
;
pharmaceutical preparations for the treatment of oncological diseases
;
pharmaceutical preparations for the treatment of oncological disorders
;
pharmaceutical preparations for the treatment of tumours
;
pharmaceutical preparations for treating arthritis
;
pharmaceutical preparations for treating gastrointestinal disorders
;
pharmaceutical preparations for treating malignant tumours
;
pharmaceutical preparations for treating rheumatological diseases
;
pharmaceutical preparations for treatment of cancer
;
pharmaceutical preparations for treatment of digestive system disorders
;
pharmaceutical preparations for treatment of tumours
;
pharmaceutical preparations for use in hematology
;
pharmaceutical preparations for use in oncology
;
pharmaceutical preparations for use in organ transplantation
;
pharmaceutical preparations for use in tissue transplantation
;
preparations for detecting genetic predispositions for medical purposes
;
prophylactic vaccines
;
reagents for use in medical genetic testing
;
tumour antigens
;
tumour vaccines
;
vaccines
;
vaccines for human use
;
viral vaccines.
Class 9
:
Immunostaining instruments [for scientific purposes].
Class 10
:
Apparatus for the diagnosis of autoimmune conditions
;
apparatus for ex vivo gene engineering
;
apparatus for cellular therapeutics
;
apparatus for cell therapy
;
apparatus for cellular therapy
;
apparatus for treatment of deceases using cells
;
apparatus for the diagnosis of autoimmune diseases
;
apparatus for the diagnosis of autoimmune disorders
;
apparatus for the diagnosis of inflammatory conditions
;
apparatus for the diagnosis of inflammatory diseases
;
apparatus for the diagnosis of inflammatory disorders
;
apparatus for the diagnosis of oncological conditions
;
apparatus for the diagnosis of oncological diseases
;
apparatus for the diagnosis of oncological disorders
;
apparatus for tumour diagnosis
;
diagnostic apparatus for medical purposes
;
diagnostic imaging apparatus for medical use
;
diagnostic instruments for medical use
;
diagnostic testing apparatus for use in immunoassay procedure (medical)
;
genetic testing apparatus for medical purposes.
Class 42
:
Analysis in the field of molecular biology
;
analysis of human serum for medical research
;
analysis of human tissues for medical research
;
biochemical research and analysis
;
biochemical research in the field of ex vivo gene engineering
;
biochemical research in the field of cellular therapeutics
;
biochemical research in the field of cell therapy
;
biochemical research in the field of cellular therapy
;
biochemical research in the field of treatment of deceases using cells
;
biological laboratory services
;
biological research
;
biological research and analysis
;
biological research laboratory services
;
biological research services
;
biological research, clinical research and medical research
;
biomedical research services
;
biotechnology research
;
blood analysis services for scientific research purposes
;
cell separation research services
;
clinical trials
;
conducting clinical trials
;
conducting clinical trials for pharmaceutical products
;
conducting clinical trials in the field of autoimmune disease therapy
;
conducting clinical trials in the field of cancer therapy
;
conducting clinical trials in the field of gene therapy
;
contract research services relating to molecular sciences
;
DNA screening for scientific research purposes
;
genetic engineering services
;
genetic engineering services relating to plants
;
genetic research
;
genetic testing for scientific research purposes
;
laboratory (scientific) services
;
laboratory research
;
laboratory research in the field of gene expression
;
laboratory research services relating to pharmaceuticals
;
laboratory testing services
;
laboratory services relating to the production of monoclonal antibodies
;
laboratory testing services
;
medical and pharmacological research services
;
medical laboratory services
;
medical research
;
medical research laboratory services
;
medical research services
;
pharmaceutical research and development
;
pharmaceutical research and development services
;
pharmaceutical research services
;
preparation of biological samples for analysis in research laboratories
;
preparation of biological samples for research purposes
;
preparation of biological samples for testing and analysis in research laboratories
;
product research and development
;
research and development for the pharmaceutical industry
;
research and development in the field of biotechnology
;
research and development in the field of diagnostic preparations
;
research and development in the field of immunology
;
research and development in the pharmaceutical and biotechnology fields
;
research and development of new products
;
research and development of new products for third parties in the field of autoimmunity, cancer and rheumatoid heart disease
;
research and development of vaccines and medicines
;
research and development services in the field of antibodies
;
research and development services in the field of antibody technology
;
research and development services in the field of immunology
;
research and development services in the field of microorganisms and cells
;
research and development services relating to vaccines
;
research in the field of autoimmune disease
;
research in the field of gene therapy
;
research in the field of genetic engineering
;
research in the field of inflammatory diseases
;
research in the field of oncology
;
research laboratories
;
research laboratory services
;
research of pharmaceuticals
;
research on the subject of pharmaceuticals
;
research relating to biotechnology
;
research relating to medicine
;
research relating to molecular services
;
research relating to pharmaceuticals
;
research relating to science
;
research and development services in the field of immunology
;
scientific investigations for medical purposes
;
scientific laboratory services
;
scientific research
;
scientific research and analysis
;
scientific research and development
;
scientific research for medical purposes
;
scientific research for medical purposes in the area of cancerous disease
;
scientific research in the field of genetics and genetic engineering
;
scientific research relating to biology
;
scientific research relating to cellular therapeutics
;
scientific research relating to genetics
;
scientific research relating to immuntherapeutics
;
scientific research relating to prophylactic vaccines
;
scientific research services
;
scientific services and research relating thereto
;
scientific services relating to the isolation and cultivation of human tissue and cells
;
scientific testing services.
Class 44
:
Blood bank services
;
medical clinic services
;
therapy services
;
blood banks
;
medical clinics
;
clinic (medical-) services
;
health clinic services [medical]
;
medical and health care clinics
;
providing personalized therapy
;
providing personalized medical and health care services
;
provision of medical services
;
medical testing services relating to the diagnosis and treatment of disease
;
medical testing services relating to ex vivo gene engineering
;
medical testing services relating to cellular therapeutics
;
medical testing services relating to cell therapy
;
medical testing services relating to cellular therapy
;
medical testing services relating to treatment of deceases using cells
;
medical services relating to the removal, treatment and processing of human blood
;
medical services for the treatment of cancer, autoimmune disease or inflammatory disease
;
medical services for the treatment of conditions of the human body
;
medical screening services relating to oncological disease, autoimmune disease or inflammatory disease
;
medical care and analysis services relating to patient treatment
;
medical diagnostic services
;
medical health assessment services
;
medical laboratory services for the analysis of samples taken from patients
;
medical laboratory services for the analysis of blood samples taken from patients
;
medical analysis services
;
medical analysis services relating to the treatment of persons
;
medical analysis services relating the treatment of patients
;
medical analysis services for the diagnosis of cancer
;
medical analysis services for cancer diagnosis and prognosis
;
medical and health services relating to DNA, genetics and genetic testing
;
medical and health care services
;
medical services in the field of oncology
;
genetic testing for medical purposes.